InvestSMART
  1. Home
  2. Research & Advice
  3. Research Tools
  4. Shares
  5. Betashares Global Healthcare ETF - Currency Hedged (DRUG)
  6. Company Announcements

Betashares Global Healthcare ETF - Currency Hedged (ASX: DRUG) - Announcements

- Current share price for DRUG : $8.530

Betashares Global Healthcare ETF - Currency Hedged (DRUG) is an Exchange Traded Fund - commonly known as an ETF. For more details about how ETFs work, feel free to check out our What is an ETF? overview. Betashares Global Healthcare ETF -Currency Hedged (DRUG) provides simple, cost-effective and transparent exposure to the largest companies in the global healthcare sector. The Fund aims to track the performance of an index (before fees and expenses) which provides exposure to the performance of the largest global healthcare companies by market capitalization (excluding companies in Australia), hedged into Australian dollars.

Latest company announcements for Betashares Global Healthcare ETF - Currency Hedged (DRUG)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$192 Estimated Annual Distribution Component Information 7 Jul 2020 12:47PM $6.630 $8.530 risen by 28.66%
$192 Units on Issue Disclosure - June 2020 6 Jul 2020 3:07PM $6.670 $8.530 risen by 27.89%
$192 DRP Issue Price 1 Jul 2020 6:01PM $6.520 $8.530 risen by 30.83%
$192 Final Distribution Announcement 30 Jun 2020 7:05PM $6.480 $8.530 risen by 31.64%
$192 Estimated Distribution Announcement 29 Jun 2020 7:14PM $6.460 $8.530 risen by 32.04%
$192 Distribution Timetable 24 Jun 2020 11:04AM $6.620 $8.530 risen by 28.85%
$192 Units on Issue Disclosure - May 2020 4 Jun 2020 11:33AM $6.630 $8.530 risen by 28.66%
$192 Units on Issue Disclosure - Apr 2020 6 May 2020 2:48PM $6.580 $8.530 risen by 29.64%
$192 Units on Issue Disclosure - Mar 2020 7 Apr 2020 2:51PM $6.060 $8.530 risen by 40.76%
$192 Units on Issue Disclosure - Feb 2020 5 Mar 2020 3:21PM $6.420 $8.530 risen by 32.87%
$192 Units on Issue Disclosure - Jan 2020 6 Feb 2020 3:02PM $6.820 $8.530 risen by 25.07%
$192 Indicative 2020 Distributions Calendar 31 Jan 2020 4:31PM $6.620 $8.530 risen by 28.85%
$192 Estimated Distribution Component Information 8 Jan 2020 4:59PM $6.590 $8.530 risen by 29.44%
$192 Units on Issue Disclosure - Dec 2019 7 Jan 2020 5:42PM $6.630 $8.530 risen by 28.66%
$192 DRP Issue Price 2 Jan 2020 5:59PM $6.660 $8.530 risen by 28.08%
$192 Final Distribution Announcement 2 Jan 2020 8:13AM $6.660 $8.530 risen by 28.08%
$192 Estimated Distribution Announcement 30 Dec 2019 6:09PM $6.690 $8.530 risen by 27.50%
$192 Distribution Timetable 23 Dec 2019 5:39PM $6.610 $8.530 risen by 29.05%
$192 Units on Issue Disclosure - Nov 2019 5 Dec 2019 4:51PM $6.430 $8.530 risen by 32.66%
$192 Units on Issue Disclosure - Oct 2019 6 Nov 2019 4:16PM $6.140 $8.530 risen by 38.93%
$192 Units on Issue Disclosure - Sep 2019 7 Oct 2019 4:16PM $5.860 $8.530 risen by 45.56%
$192 Annual Report 30 Sep 2019 4:39PM $5.900 $8.530 risen by 44.58%

101 - 122 of 122 results

Page 5 of 5

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.